Zhaoke Ophthalmology (HKSE:06622) EBIT per Share : HK$-0.44 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology EBIT per Share?

Zhaoke Ophthalmology's EBIT per Share for the six months ended in Jun. 2024 was HK$-0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.44.

During the past 3 years, the average EBIT per Share Growth Rate was -51.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zhaoke Ophthalmology's EBIT per Share or its related term are showing as below:

HKSE:06622' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -59.2 Med: -55.3 Max: -51.4
Current: -51.4

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Zhaoke Ophthalmology was -51.40% per year. The lowest was -59.20% per year. And the median was -55.30% per year.

HKSE:06622's 3-Year EBIT Growth Rate is ranked worse than
89.44% of 1250 companies
in the Biotechnology industry
Industry Median: 2.8 vs HKSE:06622: -51.40

Zhaoke Ophthalmology's EBIT for the six months ended in Jun. 2024 was HK$-76.42 Mil.

Zhaoke Ophthalmology EBIT per Share Historical Data

The historical data trend for Zhaoke Ophthalmology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology EBIT per Share Chart

Zhaoke Ophthalmology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-0.25

-1.61

-6.32

-0.83

-0.76

Zhaoke Ophthalmology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial					-0.35	-0.50	-0.46	-0.30	-0.14

Zhaoke Ophthalmology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zhaoke Ophthalmology's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-411.881	/	543.923
=	-0.76

Zhaoke Ophthalmology's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-76.422	/	546.139
=	-0.14

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.44

Zhaoke Ophthalmology (HKSE:06622) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zhaoke Ophthalmology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhaoke Ophthalmology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN

Website

https://www.zkoph.com

Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company. It is dedicated to the research, development, and commercialization of therapies that address unmet medical needs in China. The company has built a comprehensive ophthalmic drug pipeline of 26 candidates that covers ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. It has also established an ophthalmic manufacturing facility and is assembling an experienced marketing team in anticipation of a near-term product launch.

Executives

Gic Private Limited	2201 Interest of corporation controlled by you
Mak Siu Hang Viola	2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd	2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd	2101 Beneficial owner
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Fidelity China Special Situations Plc	2101 Beneficial owner
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Vms Holdings Limited	2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited	2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p.	2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p.	2201 Interest of corporation controlled by you

Zhaoke Ophthalmology Headlines

No Headlines